Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
13.98
+0.79 (5.99%)
Aug 4, 2026, 3:00 PM CST
SHA:688488 Market Cap
SHA:688488 has a market cap or net worth of 5.88 billion as of August 4, 2026. Its market cap has decreased by -12.57% in one year.
Market Cap
5.88B
Enterprise Value
6.18B
Revenue
699.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.98
ChartMarket Cap Chart
Since July 20, 2020, SHA:688488's market cap has decreased from 12.99B to 5.88B, a decrease of -54.70%. That is a compound annual growth rate of -12.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 5.88B | -14.39% |
| Dec 31, 2025 | 6.87B | 107.76% |
| Dec 31, 2024 | 3.31B | -37.17% |
| Dec 29, 2023 | 5.26B | 18.91% |
| Dec 30, 2022 | 4.43B | -32.31% |
| Dec 31, 2021 | 6.54B | -37.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Thera Solutions | 7.08B |
| Shanghai OPM Biosciences | 6.88B |
| Zhejiang Ausun Pharmaceutical | 6.12B |
| Wuhan Keqian Biology Co.,Ltd | 6.04B |
| Chengdu Kanghua Biological Products | 6.01B |
| Hangzhou Biotest Biotech | 5.59B |
| Youcare Pharmaceutical Group | 5.46B |
| Novogene | 5.15B |